Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04224636
Title Atezolizumab/Bevacizumab Followed by On-demand TACE or Initial Synchronous Treatment With TACE and Atezolizumab/Bevacizumab (DEMAND)
Acronym DEMAND
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Ludwig-Maximilians - University of Munich
Indications
Therapies
Age Groups: adult | senior
Covered Countries DEU

Facility Status City State Zip Country Details
University of Bonn RECRUITING Bonn Germany Details
University Hospital Cologne RECRUITING Köln 50931 Germany Details
Hospital of the University of Munich RECRUITING Munich 81377 Germany Details
Klinikum Rechts der Isar of the Technical University Munich RECRUITING Munich 81675 Germany Details
University Hospital Regensburg RECRUITING Regensburg 93053 Germany Details
University Hospital Tübingen RECRUITING Tübingen 72076 Germany Details
Würzburg University Hospital RECRUITING Würzburg Germany Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field